Rinath M. Jeselsohn

Dana-Farber Cancer Inst

$2,766,775

Attributed

$2,766,775

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $554.9K · FY2015–23

$1M$750K$500K$250K$0

'15

'16

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$2,766,775 · 2

By mechanism

R01$1,881,175 · 1

K08$885,600 · 1

Top collaborators

No co-investigators on record.

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Cloud Peter Paweletz$2,458,484
Heather Anne Parsons$1,292,279
Gordon J Harris$11,607,211
Lorenzo Trippa$1,815,428
Qianben Wang$7,988,225

Others in their field

Top investigators on “Pharmaceutical Preparations”

Sonia M Thomas · Research Triangle Institute$701,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947

Research focus

Pharmaceutical PreparationsResistanceFulvestrantNeoplasm MetastasisPre-ClinicalMolecularEsr1 GeneEstrogen ReceptorsHormone TherapyMutantLigand Binding DomainMutationMalignant Breast NeoplasmMetastatic Breast CancerEndocrineCdk4 GeneEstrogen Receptor PositiveCell Cycle RegulationGenerationsCell LineGrowthGenome-WideDesignResistance Development